MX2017004735A - Compuestos de carboxilato de fenilcetona y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis. - Google Patents

Compuestos de carboxilato de fenilcetona y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis.

Info

Publication number
MX2017004735A
MX2017004735A MX2017004735A MX2017004735A MX2017004735A MX 2017004735 A MX2017004735 A MX 2017004735A MX 2017004735 A MX2017004735 A MX 2017004735A MX 2017004735 A MX2017004735 A MX 2017004735A MX 2017004735 A MX2017004735 A MX 2017004735A
Authority
MX
Mexico
Prior art keywords
mcooh
osteoporosis
nch3
cooh
prevention
Prior art date
Application number
MX2017004735A
Other languages
English (en)
Inventor
Gagnon Lyne
Grouix Brigitte
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of MX2017004735A publication Critical patent/MX2017004735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Abstract

La presente invención se refiere al uso de compuestos para prevenir y/o tratar la osteoporosis, para estimular la formación ósea, para estimular la remodelación ósea, para estimular la diferenciación y la mineralización de los osteoblastos, o para inhibir la resorción ósea en un sujeto. Estos usos novedosos se han descubierto para los compuestos representados por la fórmula I y las sales farmacéuticamente aceptables de estos, en donde: R1 y R2 son independientemente iguales a H, F o OH; A es (CH2)mCOOH, W(CH2)mCOOH, o Y-CH(COOH)-(CH2)p-CH3 cuando B es H, o B es (CH2)mCOOH, W(CH2)mCOOH, o Y-CH(COOH)-(CH2)p-CH3 cuando A es H; o A y B se unen covalentemente para formar un cicloalquilo de cinco (5), seis (6) o siete (7) miembros sustituidos con COOH; donde: Y es O, S, HN o CH2; W es 0, S o NH; m es 0-2 y p es 3-7; D es CO(CH2)nCH3 o CHOH(CH2)nCH3 o 0(CH2)nCH3 donde n es 2-6; y E es H o F.
MX2017004735A 2014-10-10 2015-10-08 Compuestos de carboxilato de fenilcetona y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis. MX2017004735A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462062660P 2014-10-10 2014-10-10
PCT/CA2015/000530 WO2016054725A1 (en) 2014-10-10 2015-10-08 Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

Publications (1)

Publication Number Publication Date
MX2017004735A true MX2017004735A (es) 2017-11-17

Family

ID=55652426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004735A MX2017004735A (es) 2014-10-10 2015-10-08 Compuestos de carboxilato de fenilcetona y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis.

Country Status (22)

Country Link
US (1) US10925846B2 (es)
EP (1) EP3204000B1 (es)
JP (1) JP6700638B2 (es)
KR (1) KR20170066613A (es)
CN (1) CN106999459B (es)
AR (1) AR102247A1 (es)
AU (1) AU2015330642B2 (es)
BR (1) BR112017007386A2 (es)
CA (1) CA2963358C (es)
DK (1) DK3204000T3 (es)
ES (1) ES2794782T3 (es)
IL (1) IL251409B (es)
MX (1) MX2017004735A (es)
MY (1) MY187511A (es)
PH (1) PH12017500636A1 (es)
PL (1) PL3204000T3 (es)
PT (1) PT3204000T (es)
RU (1) RU2712027C2 (es)
SG (1) SG11201702810TA (es)
TW (1) TWI723962B (es)
UY (1) UY36355A (es)
WO (1) WO2016054725A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863270B2 (en) * 2005-05-13 2011-01-04 Synta Pharmaceuticals Corp. IL-12 modulatory compounds
EP2488208B1 (en) * 2009-10-14 2018-11-21 The Governors of the University of Alberta Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
MY162420A (en) * 2010-10-27 2017-06-15 Prometic Pharma Smt Ltd Compounds and compositions for the treatment of cancer
JP6055771B2 (ja) * 2010-10-27 2016-12-27 プロメティック・ファーマ・エスエムティ・リミテッドＰｒｏｍｅｔｉｃ Ｐｈａｒｍａ Ｓｍｔ Ｌｉｍｉｔｅｄ カルボン酸フェニルケトン化合物およびその薬学的使用
TW201305098A (zh) * 2010-10-27 2013-02-01 Prometic Biosciences Inc 用於糖尿病的化合物和藥物組合物
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis

Also Published As

Publication number Publication date
TWI723962B (zh) 2021-04-11
AR102247A1 (es) 2017-02-15
DK3204000T3 (da) 2020-04-06
IL251409A0 (en) 2017-05-29
JP2017530179A (ja) 2017-10-12
WO2016054725A1 (en) 2016-04-14
US10925846B2 (en) 2021-02-23
US20190038580A1 (en) 2019-02-07
EP3204000A1 (en) 2017-08-16
TW201618761A (zh) 2016-06-01
SG11201702810TA (en) 2017-05-30
JP6700638B2 (ja) 2020-05-27
RU2017116154A3 (es) 2019-05-06
AU2015330642A1 (en) 2017-05-11
ES2794782T3 (es) 2020-11-19
RU2017116154A (ru) 2018-11-12
UY36355A (es) 2016-06-01
BR112017007386A2 (pt) 2018-01-23
CN106999459A (zh) 2017-08-01
KR20170066613A (ko) 2017-06-14
EP3204000A4 (en) 2018-06-20
CA2963358C (en) 2023-03-07
CN106999459B (zh) 2020-07-10
PH12017500636A1 (en) 2017-09-25
IL251409B (en) 2020-08-31
RU2712027C2 (ru) 2020-01-27
PL3204000T3 (pl) 2020-07-27
CA2963358A1 (en) 2016-04-14
MY187511A (en) 2021-09-24
PT3204000T (pt) 2020-05-06
AU2015330642B2 (en) 2019-07-04
EP3204000B1 (en) 2020-01-08

Similar Documents

Publication Publication Date Title
EA201692095A1 (ru) Имидазо[4,5-c]хинолин-2-оновые соединения и их применение в лечении рака
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
NZ730730A (en) Novel carboxylic acid compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
MX2013011589A (es) Metodos y composiciones para tratar enfermedad de parkinson.
MX2016015248A (es) Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal.
MX2017004600A (es) Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos.
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
MX2015011273A (es) Uso de derivados de pirazolopirimidina para el tratamiento de trastornos relacio nados con la fosfoinositida 3-cinasa delta.
NZ726366A (en) Syk inhibitors
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
NZ708928A (en) Mannose derivatives for treating bacterial infections
MX2018004664A (es) Antagonistas de ep4.
PH12016502394A1 (en) 1, 3, 4-thiadiazole compounds and their use in treating cancer
MX2012001134A (es) Composiciones y metodos para inhibicion de la via jak.
SG10201810404XA (en) Combination comprising a glucocorticoid and edo-s101
BR112017005242A2 (pt) composto, composição farmacêutica, e, composto para uso.
BR112017007426A2 (pt) compostos aromáticos substituídos e composições farmacêuticas para prevenir e tratar osteoporose
NZ734260A (en) Substituted triazoles and methods relating thereto
IN2012DN00763A (es)
MY171832A (en) 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease
MX2018014165A (es) Compuestos heterociclicos utiles como agentes antibacterianos y metodo de produccion.
PH12017500636A1 (en) Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
NZ737820A (en) Mannose derivatives for treating bacterial infections
TN2017000448A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease

Legal Events

Date Code Title Description
FG Grant or registration